EUVIMEDEUVIMED entdecken
KommentarLeserbriefNetzwerk-MetaanalyseOpen Access · CC BY-NC 4.0

From post-transplant outcomes to listing decisions: Clinical implications of comparing expanded hepatocellular carcinoma transplant criteria: Letter to the editor on “Network meta-analysis and validation study of expanded liver transplantation criteria for hepatocellular carcinoma: Significant role of alpha-fetoprotein”

Bo Ni, Hairui Wang

Clinical and Molecular Hepatology · 01.07.2026 · 32 (3) · e315-e316

DOI: 10.3350/cmh.2026.0124 ↗

Kurz gefasst

Kommentar in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.07.2026. Verfasst von Bo Ni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

From post-transplant outcomes to listing decisions: Clinical implications of comparing expanded hepatocellular carcinoma transplant criteria: Letter to the editor on "Network meta-analysis and validation study of expanded liver transplantation criteria for hepatocellular carcinoma: Significant role of alpha-fetoprotein"

Schlagwörter

Stichwörter der Autor:innen

Alpha-fetoproteinExpanded criteriaHepatocellular carcinomaLiver transplantationMilan criteria

Autor:innen und Institutionen

  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Catheter Intervention, Liaoyang Central Hospital, Liaoyang, China.
  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China. wanghr@sj-hospital.org.

Zitieren

APA

Ni, B., & Wang, H. (2026). From post-transplant outcomes to listing decisions: Clinical implications of comparing expanded hepatocellular carcinoma transplant criteria: Letter to the editor on “Network meta-analysis and validation study of expanded liver transplantation criteria for hepatocellular carcinoma: Significant role of alpha-fetoprotein”. Clinical and Molecular Hepatology, 32(3), e315-e316. https://doi.org/10.3350/cmh.2026.0124

Vancouver

Ni B, Wang H. From post-transplant outcomes to listing decisions: Clinical implications of comparing expanded hepatocellular carcinoma transplant criteria: Letter to the editor on “Network meta-analysis and validation study of expanded liver transplantation criteria for hepatocellular carcinoma: Significant role of alpha-fetoprotein”. Clinical and Molecular Hepatology. 2026;32(3):e315-e316. doi:10.3350/cmh.2026.0124

BibTeX
@article{Ni2026,
  author = {Ni, Bo and Wang, Hairui},
  title = {From post-transplant outcomes to listing decisions: Clinical implications of comparing expanded hepatocellular carcinoma transplant criteria: Letter to the editor on “Network meta-analysis and validation study of expanded liver transplantation criteria for hepatocellular carcinoma: Significant role of alpha-fetoprotein”},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {e315--e316},
  doi = {10.3350/cmh.2026.0124}
}
Kostenlos starten →